期刊
CANCER LETTERS
卷 301, 期 2, 页码 203-211出版社
ELSEVIER IRELAND LTD
DOI: 10.1016/j.canlet.2010.12.005
关键词
Apoptosis; CD95 (Fas/APO1); Renal cell cancer; Prognostic factors
类别
资金
- University of Heidelberg
- Deutsche Krebshilfe
- Tissue Bank of the National Center for Tumor Diseases Heidelberg
CD95 (Fas/APO1) is one of the best known members of the death receptor family which can either mediate apoptosis or activate tumor-promoting pathways. Using a tissue microarray we investigated the association between the expression of CD95 and prognosis in 617 patients with renal cell carcinomas (RCCs). CD95 was expressed in the vast majority of RCCs. High CD95 expression was associated with lymph node metastasis and correlated negatively with disease-specific survival. Multivariate Cox regression analysis confirmed CD95 expression as an independent prognostic factor. In conclusion, high CD95 expression is a negative independent prognostic factor in RCCs which could be used to identify high-risk patients with a poor clinical prognosis. (c) 2010 Elsevier Ireland Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据